Maharashtra

EPIDermizz, a skincare division of Nippon Seiyaku Pvt. Ltd. Nippon Seiyaku Pvt. Ltd. is an associate of Nippon Seiyaku co. Ltd., Japan which have been started its operation in Indian Market in 2001. Having robust brand NUTRIFACTS, Nippon is one of the most admired companies in pediatric fraternity. It has the history of pioneering in the area of nutrition by launching molecules like Methylcobalamine, Benfothiamine and Co Enzyme Q10 first time in India.

Abbott India Limited is a subsidiary of Abbott Laboratories, USA, a global, iversified health care company devoted to the discovery, development, manufacture and marketing of pharmaceutical, diagnostic, nutritional and hospital products. The company now employs approximately 70,000 people and markets its products in 130 countries worldwide.

The Advanced Centre for Treatment, Research and Education in Cancer (ACTREC) is the new state-of-the-art R&D satellite of the Tata Memorial Centre (TMC), which also includes under its umbrella the Tata Memorial Hospital (TMH), the largest cancer hospital in Asia.

National Institute for Research in Reproductive Health (NIRRH), formerly known as Institute for Research in Reproduction is a premier research institute of the Indian Council of Medical Research (ICMR). It is situated in the vicinity of a number of hospitals and research institutes in central Mumbai.

With USFDA approvable API facility - Mac-Chem has carved a niche for itself in the exceedingly competitive and quality-conscious sphere of pharmaceuticals manufacturing. The paradigm shift of leading Indian pharmaceutical companies to target low volume and blockbuster products for regulated markets has been the inspiration behind the launch.

Umrao Hospitals is a 330 bedded Multi-speciality tertiary care institute which is slated to be North Mumbai’s largest health care project. It has been envisioned as a healthcare destination where patients receive care in a truly restorative environment. It will deliver hi-end clinical care across major medical specialties through comprehensive solutions including consultancy, diagnostics and therapy.

The Tata Memorial Hospital was initially commissioned by the Sir Dorabji Tata Trust on 28 February 1941 as a center with enduring value and a mission for concern for the Indian people.

D.R. johns Lab. is an integrated pharmaceutical major with diversified competencies in bulk drugs, formulations and drug discovery, with a strong orientation towards the advanced regulated markets. A snow-balling momentum in establishing new facilities both in bulk drugs and formulations for the regulated markets, securing approvals from international regulatory authorities and generating intellectual property has resulted in a strategic transformation in Dr johns Lab’s business profile.